RIQAS Maternal Screening by Randox Laboratories Ltd.
Manufacturer Randox Laboratories Ltd.
The RIQAS Maternal Screening EQA programme is designed to monitor the performance of screening tests used during the first and second trimester of pregnancy to assess the risk of Down’s syndrome, Spina Bifida and Trisomy 18.Accredited to ISO/IEC 17043Lyophilised for enhanced stability100% human serumMonthly reportingSubmit results and view reports online via RIQAS.NetRegister up to five instruments at no extra costSuitable for first and second trimester screeningCat No - Kit Size - Frequency - C... Read more
The supplier does not provide quotations for this product through SelectScience. Browse these related products instead
_-_Product_11.jpg.ashx?width=100&height=100&bgcolor=white)
RIQAS Maternal Screening
The RIQAS Maternal Screening EQA programme is designed to monitor the performance of screening tests used during the first and second trimester of pregnancy to assess the risk of Down’s syndrome, Spina Bifida and Trisomy 18.
Cat No - Kit Size - Frequency - Cycle Start - Parameters
- RQ9137 - 12 x 1ml - Monthly (1 x 12 month cycle) - January - 6
Parameters
- AFP
- Inhibin A
- hCG, free beta
- PAPP-A
- hCG, total
- Unconjugated Oestriol
Product Overview
